Taysha Gene Therapies, Inc. TSHA Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.28B.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s market capitalization?
- Taysha Gene Therapies, Inc. (TSHA) reported market capitalization of $1.28B in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s market capitalization changed year-over-year?
- Taysha Gene Therapies, Inc.'s market capitalization increased by 350.6% year-over-year, from $284.95M to $1.28B.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s market capitalization?
- Over 5 years (2020 to 2025), Taysha Gene Therapies, Inc.'s market capitalization has grown at a 12.0% compound annual growth rate (CAGR), from $854.96M to $1.51B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.